A Sustained Virologic Response Is Durable in Patients With Chronic Hepatitis C Treated With Peginterferon Alfa-2a and Ribavirin

Overview of attention for article published in Gastroenterology, July 2010

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (90th percentile)
High Attention Score compared to outputs of the same age and source (84th percentile)

Mentioned by

blogs: 1 blog
policy: 1 policy source

f1000: 1 research highlight platform

Citations

dimensions_citation: 278 Dimensions

Readers on

mendeley: 134 Mendeley
citeulike: 1 CiteULike

Summary Blogs Policy documents Research highlights Dimensions citations

So far, Altmetric has seen 2 policy documents that reference this research output.

Sofosbuvir–velpatasvir–voxilaprevir for treating chronic hepatitis C: Committee papers

Cited by National Institute for Health and Care Excellence on 11 Jan 2018

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

Sofosbuvir–velpatasvir for treating chronic hepatitis C: Committee papers

Cited by National Institute for Health and Care Excellence on 23 Sep 2016

The National Institute for Health and Care Excellence (NICE) in the UK provides national guidance and advice to improve health and social care.

This page shows the most recent policy documents that mention this research output.

Click here to find out how to access more activity.